Northstar Advisory Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $341K | Buy |
437
+1
| +0.2% | +$780 | 0.17% | 83 |
|
|
2025
Q1 | $360K | Hold |
436
| – | – | 0.24% | 76 |
|
|
2024
Q4 | $337K | Sell |
436
-1
| -0.2% | -$772 | 0.17% | 80 |
|
|
2024
Q3 | $387K | Sell |
437
-2
| -0.5% | -$1.77K | 0.2% | 77 |
|
|
2024
Q2 | $397K | Hold |
439
| – | – | 0.23% | 70 |
|
|
2024
Q1 | $339K | Sell |
439
-53
| -11% | -$40.9K | 0.21% | 73 |
|
|
2023
Q4 | $287K | Buy |
492
+2
| +0.4% | +$1.17K | 0.17% | 74 |
|
|
2023
Q3 | $263K | Sell |
490
-453
| -48% | -$243K | 0.19% | 75 |
|
|
2023
Q2 | $442K | Sell |
943
-1,670
| -64% | -$783K | 0.29% | 55 |
|
|
2023
Q1 | $897K | Sell |
2,613
-1,814
| -41% | -$623K | 0.67% | 35 |
|
|
2022
Q4 | $1.62M | Buy |
4,427
+842
| +23% | +$308K | 1.28% | 14 |
|
|
2022
Q3 | $1.16M | Buy |
3,585
+1,470
| +70% | +$475K | 1.04% | 19 |
|
|
2022
Q2 | $686K | Sell |
2,115
-33
| -2% | -$10.7K | 0.51% | 29 |
|
|
2022
Q1 | $615K | Sell |
2,148
-351
| -14% | -$100K | 0.4% | 55 |
|
|
2021
Q4 | $690K | Buy |
+2,499
| New | +$690K | 0.41% | 45 |
|
|
2021
Q3 | – | Sell |
-2,163
| Closed | -$496K | – | 84 |
|
|
2021
Q2 | $496K | Buy |
2,163
+229
| +12% | +$52.5K | 0.31% | 59 |
|
|
2021
Q1 | $361K | Sell |
1,934
-101
| -5% | -$18.9K | 0.28% | 65 |
|
|
2020
Q4 | $344K | Buy |
+2,035
| New | +$344K | 0.29% | 69 |
|